NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.0849
0.00 (0.00%)
Aug 8, 2025, 4:00 PM - Market closed
Market Cap49.15M
Revenue (ttm)n/a
Net Income (ttm)-24.11M
Shares Out 17.29M
EPS (ttm)-1.92
PE Ration/a
Forward PE7.72
Dividendn/a
Ex-Dividend Daten/a
Volume5,080
Open0.0787
Previous Close0.0849
Day's Range0.0787 - 0.0849
52-Week Range0.0395 - 0.5000
Beta1.60
Analystsn/a
Price Targetn/a
Earnings DateMar 28, 2025

About ATVI

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

News

There is no news available yet.